Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.
Press releases published on April 27, 2025
NOVONIX Appoints Michael O’Kronley as Chief Executive Officer
GlobeNewswire
·
April 27, 2025
CHATTANOOGA, Tenn., April 27, 2025 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), a leading battery materials and technology company today announced the appointment of Michael O’Kronley as Chief Executive Officer, …
Perseus Mining Proceeds with Development of Nyanzaga Gold Project
GlobeNewswire
·
April 27, 2025
Perth, April 28, 2025 (GLOBE NEWSWIRE) -- PERSEUS MINING PROCEEDS WITH DEVELOPMENT OF THE NYANZAGA GOLD PROJECT overview Perth, Western Australia/ April 28, 2025/ Perseus Mining Limited (ASX/TSX: PRU) is pleased to announce that a Final Investment Decision …
Alkane and Mandalay Combine to Create Growing Gold and Antimony Producer
GlobeNewswire
·
April 27, 2025
Creates powerful platform underpinned by a shared vision for growth. Three cash-generating mines in premier mining jurisdictions with strong organic growth. Projected gold equivalent production of ~160,0001 ounces in 2025, increasing to over ~180,0002 …
BDTCOIN (BDTC) Is Listed On AscendEX! Trade Now!
GlobeNewswire
·
April 27, 2025
FERNANDINA BEACH, Fla., April 27, 2025 (GLOBE NEWSWIRE) -- BDTCOIN, the world’s first gold-backed cryptocurrency, is now expanding its reach through listing on AscendEX. AscendEX is one of the fastest-growing centralised crypto trading exchanges over 90 M+ …
Y-mAbs Presents Translational Pharmacokinetics of CD38-SADA from Pretargeted RIT Platform at 2025 American Association for Cancer Research (AACR) Annual Meeting
GlobeNewswire
·
April 27, 2025
NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based …
Precede Biosciences Presents Data at AACR 2025 Demonstrating Ability to Resolve Gene Expression for Thousands of Tumor-Specific Genes from a Simple Blood Test
GlobeNewswire
·
April 27, 2025
Comprehensive epigenomic platform enables systematic and quantitative prediction of tumor gene expression from cell-free DNA Genes include key targets for next generation precision medicines, such as NECTIN4, B7H4, HER3, DLL3, MUC1, MET, and HER2 and …
XRP News: XenDex Fills Up More Than 30% of Its Presale as Community Activity Grows Rapidly
GlobeNewswire
·
April 27, 2025
SYDNEY, April 27, 2025 (GLOBE NEWSWIRE) -- The pace is unstoppable and XenDex is leading the charge. Just about three days into its presale, more than 30% of the $XDX token allocation has already been claimed, cementing XenDex’s position as one of the …
Abpro and Celltrion Unveil Preclinical Data for ABP-102/CT-P72 at AACR 2025, Showcasing Potential Best-in-Class HER2 x CD3 T-Cell Engager
GlobeNewswire
·
April 27, 2025
Data suggest potential for superior tumor selectivity, potent efficacy, and improved safety profile Abpro and Celltrion have a strategic partnership for worldwide development and commercialization of ABP-102/CT-P72 HER2-positive cancers represent up to 30 …
JETOUR Showcases Advanced Off-Road Technology at Auto Shanghai 2025 with Global Media Test Drive Event
GlobeNewswire
·
April 27, 2025
Shanghai, April 27, 2025 (GLOBE NEWSWIRE) -- JETOUR, the innovative auto brand, hosted an test drive event for over 200 global media and influencers from the Middle East, South America, Africa, Asia-Pacific, and the CIS region. The event, held at the …
Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting
GlobeNewswire
·
April 27, 2025
REDWOOD CITY, Calif., April 27, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced new clinical data for …
Mitolyn Reviews: DO NOT Spend A Dime Until You’ve Read This Report?
GlobeNewswire
·
April 27, 2025
Albany, New York, April 27, 2025 (GLOBE NEWSWIRE) -- Various weight loss supplements make exaggerated promotional statements that obscure the real value of actual customer feedback with measurable results. The health and wellness industry welcomes Mitolyn …
SpringWorks Therapeutics Announces Expected CHMP Opinion in Q2 2025 for Nirogacestat for the Treatment of Adults with Desmoid Tumors in the European Union
GlobeNewswire
·
April 27, 2025
STAMFORD, Conn., April 27, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the Company anticipates the Committee for …
Rony Jabour to Speak on Workplace Safety at NSC Congress & Expo 2025 in Denver
EIN Presswire
·
April 27, 2025
DENVER, CO, UNITED STATES, April 26, 2025 /EINPresswire.com/ -- Rony Jabour, an occupational safety educator and founder of United Safety Net, is scheduled to speak at the National Safety Council (NSC) Congress …
UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025
GlobeNewswire
·
April 27, 2025
CORAL GABLES, Fla., April 27, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association (AUA2025 …
Best Male Enhancement Pills & Libido Booster For Men: (Penis Enlargement Pills) Over The Counter Best ED Pills Non Prescription – By Performer 8
GlobeNewswire
·
April 27, 2025
Atlantic City, New Jersey, April 27, 2025 (GLOBE NEWSWIRE) -- Best Male Enhancement Pills 2025 Review: More than 50% of men now face erectile dysfunction after the age of 40. In a few cases, men in their 20s and 30s face a similar situation. If you think …
The Real Mitolyn Weight Loss Formula is Made in FDA-Approved Lab with cGMP Standards to Provide Best-In-Class Quality
GlobeNewswire
·
April 27, 2025
New York, April 27, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: Why millions struggle with stubborn fat, low energy, and slow metabolism — and how mitochondrial dysfunction plays a hidden role. How mitochondrial health directly impacts your …
2025 (Spring) Pharmaceutical Machinery Exposition Concludes Successfully
GlobeNewswire
·
April 27, 2025
BEIJING, April 27, 2025 (GLOBE NEWSWIRE) -- On April 25, 2025, the 66th (Spring 2025) National Pharmaceutical Machinery Exposition …
Globaler Innovationsschub im Energiebereich: TERA-Award mit rekordverdächtigen 785 Einsendungen
GlobeNewswire
·
April 27, 2025
HONGKONG, April 27, 2025 (GLOBE NEWSWIRE) -- Der diesjährige TERA-Award hat Innovatoren aus aller Welt angezogen und damit frühere Teilnahmerekorde gebrochen – ein Beleg für den zunehmenden globalen Bedarf an klimatechnischen Lösungen. Der Wettbewerb für …
Auge mundial de la innovación energética: el premio TERA-Award bate un récord con 785 candidaturas
GlobeNewswire
·
April 27, 2025
HONG KONG, April 27, 2025 (GLOBE NEWSWIRE) -- Como prueba de los crecientes esfuerzos internacionales por encontrar soluciones tecnológicas al problema del clima, la edición de este año del premio TERA-Award ha atraído a innovadores de todo el mundo, …
Un record de 785 candidatures au TERA-Award illustre l'engouement international pour l'innovation énergétique
GlobeNewswire
·
April 27, 2025
HONG KONG, 27 avr. 2025 (GLOBE NEWSWIRE) -- Cette année, TERA-Award a attiré des innovateurs du monde entier et a fait exploser les records de participation des éditions précédentes, illustrant un élan mondial accru en faveur de solutions technologiques …